Insiders Zevra Therapeutics, Inc.

Equities

ZVRA

US4884452065

Real-time Estimate Cboe BZX Other stock markets 02:03:38 2024-04-29 pm EDT			5-day change	1st Jan Change
4.6 ^USD	+1.77%		+0.88%	-29.62%

Apr. 15	Zevra Therapeutics Metabolic Disorder Treatment Shows 'Meaningful Slowing of Disease Progression'	MT
Apr. 10	Zevra Therapeutics, Inc. Refinances Existing Debt with up to $100 million in Committed Capital under New Credit Facility	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zevra Therapeutics, Inc. Appoints Alvin Shih to the Board of Directors	Jan. 23	CI
XOMA Names Owen Hughes CEO, Jack Wyszomierski Chairman; to Make $1 Million Milestone Payment	Jan. 12	MT
Zevra Therapeutics Names Adrian Quartel Chief Medical Officer	Jan. 04	MT
Zevra Therapeutics Appoints Adrian Quartel as Chief Medical Officer	Jan. 04	CI
Zevra Therapeutics, Inc. Announces Executive Changes	23-10-10	CI
Zevra Therapeutics, Inc. Announces Chief Executive Officer Changes	23-10-10	CI
Zevra Therapeutics Names Neil McFarlane Chief Executive	23-10-10	MT
Zevra Therapeutics, Inc. Announces Board Changes	23-08-07	CI
Zevra Therapeutics, Inc. Announces Change of CEO, Effective June 1, 2023	23-05-08	CI
Zevra Therapeutics, Inc. Announces Board Changes	23-05-08	CI
Zevra Therapeutics Appoints Wendy Dixon, Ph.D., to Board of Directors	23-03-30	CI
KemPharm, Inc. has Changed its Name to Zevra Therapeutics, Inc	23-02-22	CI
KemPharm, Inc. Appoints Daniel Gallo as Senior Vice President of Medical Affairs and Advocacy	23-01-31	CI
KemPharm, Inc. Announces Promotion of Sven Guenther to Chief Scientific Officer and Christal Mickle to Chief Product Development Officer	23-01-11	CI
KemPharm Appoints Matthew Plooster as Chair, Richard Pascoe as CEO	23-01-09	MT
KemPharm, Inc. Announces Board and Leadership Changes	23-01-09	CI
KemPharm, Inc. Appoints Richard W. Pascoe, as Chief Executive Officer	23-01-09	CI
KemPharm, Inc. Appoints Christopher Posner as New Independent Director	22-11-29	CI
Kempharm, Inc. Appoints Tamara A. Seymour as Director and Chair of the Audit Committee	21-08-18	CI
Gordon K. Johnson Ends Employment at KemPharm, Inc. as Chief Business Officer	20-02-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Zevra Therapeutics, Inc.

Equities

ZVRA

US4884452065

Insiders

Filters